NovoCure Ltd (NAS:NVCR)
$ 20.04 0.35 (1.78%) Market Cap: 2.17 Bil Enterprise Value: 1.88 Bil PE Ratio: 0 PB Ratio: 6.01 GF Score: 69/100

Novocure Ltd at Piper Sandler Healthcare Conference Transcript

Nov 29, 2023 / 08:30PM GMT
Release Date Price: $12.35 (+1.23%)
Jason M. Bednar
Piper Sandler & Co., Research Division - Director & Senior Research Analyst

Good afternoon. I'm Jason Bednar. I cover med tech here at Piper. Next fireside chat is with NovoCure. Very happy to have with us today, Executive Chairman, Bill Doyle; and CFO, Ashley Cordova. Thanks a lot for being here, both of you. Really appreciate it.

Questions & Answers

Jason M. Bednar
Piper Sandler & Co., Research Division - Director & Senior Research Analyst

So why don't we get right Q&A. A lot going on with the business right now. We did just -- I first wanted to touch on really the latest news. We had a press release yesterday, 8-K discussing a fairly large restructuring I think the first that I can recall for the business, some headcount reductions, I think it looks to me like maybe just some good corporate hygiene. I don't -- maybe that's insensitive, but really trying to prepare the business for that next stage of growth. So I don't want to put words in your mouth, but how did you come to the kind of the conclusion that now

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot